| Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study H Petousis-Harris, J Paynter, J Morgan, P Saxton, B McArdle, ... The Lancet 390 (10102), 1603-1610, 2017 | 301 | 2017 |
| Family physician perspectives on barriers to childhood immunisation H Petousis-Harris, F Goodyear-Smith, N Turner, B Soe Vaccine 22 (17-18), 2340-2344, 2004 | 75 | 2004 |
| Vaccine injection technique and reactogenicity—evidence for practice H Petousis-Harris Vaccine 26 (50), 6299-6304, 2008 | 72 | 2008 |
| Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study T Walls, P Graham, H Petousis-Harris, L Hill, N Austin BMJ open 6 (1), e009536, 2016 | 67 | 2016 |
| Family practice nurse views on barriers to immunising children H Petousis-Harris, F Goodyear-Smith, N Turner, B Soe Vaccine 23 (21), 2725-2730, 2005 | 67 | 2005 |
| Recruitment of practices in primary care research: the long and the short of it F Goodyear-Smith, D York, H Petousis-Harris, N Turner, J Copp, N Kerse, ... Family practice 26 (2), 128-136, 2009 | 63 | 2009 |
| Impact of meningococcal group B OMV vaccines, beyond their brief H Petousis-Harris Human vaccines & immunotherapeutics 14 (5), 1058-1063, 2018 | 55 | 2018 |
| Pertussis Immunisation in Pregnancy Safety (PIPS) Study: a retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine JB Griffin, L Yu, D Watson, N Turner, T Walls, AS Howe, Y Jiang, ... Vaccine 36 (34), 5173-5179, 2018 | 53 | 2018 |
| Safety of Tdap vaccine in pregnant women: an observational study H Petousis-Harris, T Walls, D Watson, J Paynter, P Graham, N Turner BMJ open 6 (4), e010911, 2016 | 52 | 2016 |
| Assessing the safety of COVID-19 vaccines: a primer H Petousis-Harris Drug safety 43 (12), 1205-1210, 2020 | 48 | 2020 |
| Effectiveness of a group B outer membrane vesicle meningococcal vaccine in preventing hospitalization from gonorrhea in New Zealand: a retrospective cohort study J Paynter, F Goodyear-Smith, J Morgan, P Saxton, S Black, ... Vaccines 7 (1), 5, 2019 | 47 | 2019 |
| Gonococcal vaccines: public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019 SL Gottlieb, F Ndowa, EW Hook III, C Deal, L Bachmann, L Abu-Raddad, ... Vaccine 38 (28), 4362-4373, 2020 | 44 | 2020 |
| Factors associated with immunisation coverage and timeliness in New Zealand CC Grant, NM Turner, DG York, F Goodyear-Smith, HA Petousis-Harris British Journal of General Practice 60 (572), e113-e120, 2010 | 41 | 2010 |
| Immunization in the print media—Perspectives presented by the press F Goodyear-Smith, H Petousis-Harris, C Vanlaar, N Turner, S Ram Journal of health communication 12 (8), 759-770, 2007 | 38 | 2007 |
| Global landscape analysis of no-fault compensation programmes for vaccine injuries: A review and survey of implementing countries RG Mungwira, C Guillard, A Saldaña, N Okabe, H Petousis-Harris, ... PLoS One 15 (5), e0233334, 2020 | 36 | 2020 |
| Seize the moments: missed opportunities to immunize at the family practice level N Turner, C Grant, F Goodyear-Smith, H Petousis-Harris Family practice 26 (4), 275-278, 2009 | 36 | 2009 |
| Barriers to childhood immunisation among New Zealand mothers H Petousis-Harris, F Goodyear-Smith, S Godinet, N Turner | 36 | 2002 |
| Exploitation of Neisseria meningitidis Group B OMV Vaccines Against N. gonorrhoeae to Inform the Development and Deployment of Effective Gonorrhea Vaccines H Petousis-Harris, FJ Radcliff Frontiers in immunology 10, 683, 2019 | 34 | 2019 |
| Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand S Radke, H Petousis-Harris, D Watson, D Gentles, N Turner Vaccine 35 (1), 177-183, 2017 | 30 | 2017 |
| Inhaled modified angiotensin converting enzyme 2 (ACE2) as a decoy to mitigate SARS-CoV-2 infection R Ameratunga, K Lehnert, E Leung, D Comoletti, R Snell, ST Woon, ... Open Access Te Herenga Waka-Victoria University of Wellington, 2020 | 26 | 2020 |
Felicity Goodyear-SmithUniversity of Auckland在 auckland.ac.nz 的电子邮件经过验证
